Nifty
Sensex
:
:
11504.95
38845.82
-11.15 (-0.10%)
-134.03 (-0.34%)

Pharmaceuticals & Drugs

Rating :
71/99

BSE: 524280 | NSE: KOPRAN

88.45
18-Sep-2020
  • Open
  • High
  • Low
  • Previous Close
  •  87.00
  •  88.45
  •  86.15
  •  84.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  620313
  •  546.75
  •  88.45
  •  15.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 365.48
  • 11.78
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 449.01
  • N/A
  • 1.79

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 43.78%
  • 3.79%
  • 43.79%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 8.64%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.45
  • 3.94
  • 4.69

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.97
  • 9.09
  • 9.96

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.59
  • 14.42
  • 0.85

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.84
  • 9.99
  • 8.04

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.68
  • 1.82
  • 1.29

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.78
  • 7.14
  • 6.03

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
120.88
84.15
43.65%
87.38
99.71
-12.37%
100.19
105.49
-5.02%
87.78
92.15
-4.74%
Expenses
100.77
76.59
31.57%
75.92
87.93
-13.66%
88.02
89.61
-1.77%
77.13
82.08
-6.03%
EBITDA
20.11
7.56
166.01%
11.46
11.78
-2.72%
12.17
15.88
-23.36%
10.65
10.07
5.76%
EBIDTM
16.64%
8.98%
13.11%
11.82%
12.14%
15.05%
12.14%
10.93%
Other Income
3.52
2.48
41.94%
0.18
4.41
-95.92%
1.40
1.78
-21.35%
1.44
0.28
414.29%
Interest
1.86
2.09
-11.00%
2.23
2.44
-8.61%
2.62
2.15
21.86%
1.97
2.79
-29.39%
Depreciation
2.54
2.30
10.43%
2.40
2.22
8.11%
2.41
2.18
10.55%
2.48
2.19
13.24%
PBT
19.24
5.64
241.13%
6.46
11.53
-43.97%
8.53
13.33
-36.01%
7.65
5.37
42.46%
Tax
5.00
1.42
252.11%
1.65
3.85
-57.14%
2.22
2.47
-10.12%
1.98
1.08
83.33%
PAT
14.23
4.22
237.20%
4.81
7.68
-37.37%
6.31
10.86
-41.90%
5.67
4.29
32.17%
PATM
11.77%
5.02%
5.50%
7.70%
6.30%
10.30%
6.46%
4.66%
EPS
3.29
0.98
235.71%
1.11
1.77
-37.29%
1.46
2.51
-41.83%
1.31
0.99
32.32%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
396.23
359.50
357.90
313.32
309.72
296.32
325.73
302.85
250.22
198.90
192.38
Net Sales Growth
3.86%
0.45%
14.23%
1.16%
4.52%
-9.03%
7.55%
21.03%
25.80%
3.39%
 
Cost Of Goods Sold
231.72
192.78
190.88
171.87
164.89
166.92
194.27
172.22
141.88
116.77
114.40
Gross Profit
164.51
166.72
167.02
141.44
144.82
129.39
131.46
130.63
108.34
82.13
77.99
GP Margin
41.52%
46.38%
46.67%
45.14%
46.76%
43.67%
40.36%
43.13%
43.30%
41.29%
40.54%
Total Expenditure
341.84
312.80
312.47
284.27
273.60
266.09
294.29
260.25
216.57
177.75
174.33
Power & Fuel Cost
-
18.08
17.10
14.90
13.71
14.10
12.93
11.71
11.13
8.56
9.03
% Of Sales
-
5.03%
4.78%
4.76%
4.43%
4.76%
3.97%
3.87%
4.45%
4.30%
4.69%
Employee Cost
-
36.85
37.11
32.24
31.37
28.02
28.83
23.01
21.03
17.98
17.85
% Of Sales
-
10.25%
10.37%
10.29%
10.13%
9.46%
8.85%
7.60%
8.40%
9.04%
9.28%
Manufacturing Exp.
-
30.07
32.41
31.35
31.84
27.80
25.56
22.44
17.79
15.85
16.17
% Of Sales
-
8.36%
9.06%
10.01%
10.28%
9.38%
7.85%
7.41%
7.11%
7.97%
8.41%
General & Admin Exp.
-
20.99
18.92
19.20
16.93
15.68
15.38
14.46
11.32
9.86
9.08
% Of Sales
-
5.84%
5.29%
6.13%
5.47%
5.29%
4.72%
4.77%
4.52%
4.96%
4.72%
Selling & Distn. Exp.
-
9.36
9.18
9.56
8.46
9.35
8.16
8.85
6.56
5.85
4.64
% Of Sales
-
2.60%
2.56%
3.05%
2.73%
3.16%
2.51%
2.92%
2.62%
2.94%
2.41%
Miscellaneous Exp.
-
4.68
6.86
5.15
6.39
4.22
9.17
7.57
6.87
2.88
4.64
% Of Sales
-
1.30%
1.92%
1.64%
2.06%
1.42%
2.82%
2.50%
2.75%
1.45%
1.65%
EBITDA
54.39
46.70
45.43
29.05
36.12
30.23
31.44
42.60
33.65
21.15
18.05
EBITDA Margin
13.73%
12.99%
12.69%
9.27%
11.66%
10.20%
9.65%
14.07%
13.45%
10.63%
9.38%
Other Income
6.54
0.63
3.96
10.94
10.66
2.37
6.54
1.96
1.81
5.66
6.45
Interest
8.68
8.91
8.99
8.60
13.70
12.56
12.97
14.46
11.88
9.66
8.61
Depreciation
9.83
9.58
8.74
8.51
8.33
8.12
9.64
12.92
12.46
11.80
11.62
PBT
41.88
28.84
31.66
22.89
24.76
11.91
15.36
17.18
11.12
5.34
4.26
Tax
10.85
7.26
7.64
2.40
4.85
0.00
0.00
0.00
0.00
0.00
-0.27
Tax Rate
25.91%
25.66%
24.13%
10.48%
19.59%
0.00%
0.00%
0.00%
0.00%
0.00%
-6.34%
PAT
31.02
21.02
24.02
20.49
19.91
10.72
-39.12
17.18
11.12
5.34
4.53
PAT before Minority Interest
31.02
21.02
24.02
20.49
19.91
10.72
-39.12
17.18
11.12
5.34
4.53
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
7.83%
5.85%
6.71%
6.54%
6.43%
3.62%
-12.01%
5.67%
4.44%
2.68%
2.35%
PAT Growth
14.68%
-12.49%
17.23%
2.91%
85.73%
-
-
54.50%
108.24%
17.88%
 
EPS
7.16
4.85
5.55
4.73
4.60
2.48
-9.03
3.97
2.57
1.23
1.05

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
189.68
168.48
144.71
124.67
108.72
98.52
114.56
97.22
86.02
80.46
Share Capital
43.25
43.25
43.25
43.25
51.83
49.68
47.63
47.63
47.63
47.63
Total Reserves
146.43
125.23
101.46
81.42
56.89
34.65
66.93
49.59
38.39
32.84
Non-Current Liabilities
40.48
46.17
31.45
32.17
33.00
18.31
67.02
73.34
68.00
76.19
Secured Loans
0.15
0.28
0.44
0.33
0.33
0.63
0.68
2.94
5.49
7.42
Unsecured Loans
31.68
40.84
29.48
32.17
28.36
13.38
62.54
66.54
59.10
65.83
Long Term Provisions
7.20
6.42
5.14
4.59
4.31
4.31
3.55
3.60
3.16
2.84
Current Liabilities
140.05
134.71
135.53
136.49
122.08
158.21
117.45
92.75
96.43
80.65
Trade Payables
54.74
51.16
60.67
47.13
57.04
69.22
35.71
46.98
41.82
30.74
Other Current Liabilities
38.17
35.24
21.30
29.91
26.64
36.70
29.33
20.74
22.85
18.72
Short Term Borrowings
46.23
45.44
52.11
56.09
38.00
51.38
52.27
24.90
31.66
31.01
Short Term Provisions
0.91
2.87
1.45
3.36
0.41
0.90
0.14
0.12
0.12
0.18
Total Liabilities
370.21
349.36
311.69
293.33
263.80
275.04
299.03
263.31
250.45
237.30
Net Block
111.15
112.62
104.44
104.47
100.88
101.56
104.89
108.51
114.32
115.21
Gross Block
146.31
138.14
121.27
112.80
314.06
306.73
295.95
286.76
280.31
269.40
Accumulated Depreciation
35.16
25.52
16.84
8.33
213.18
205.18
191.06
178.25
165.99
154.19
Non Current Assets
147.61
141.79
118.20
113.62
109.78
105.06
139.33
140.69
143.91
147.76
Capital Work in Progress
30.24
24.29
9.93
6.29
3.13
1.23
19.76
19.85
18.92
18.96
Non Current Investment
0.02
0.02
0.05
0.05
0.11
0.11
0.81
0.81
0.81
0.96
Long Term Loans & Adv.
4.90
3.54
2.47
2.30
5.61
2.09
13.76
11.43
9.83
9.93
Other Non Current Assets
1.29
1.32
1.31
0.50
0.03
0.06
0.10
0.09
0.02
2.70
Current Assets
222.60
207.57
193.50
179.72
154.01
169.98
159.70
122.61
106.54
89.55
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
88.50
73.45
71.01
60.56
58.84
45.30
53.02
36.74
35.15
32.11
Sundry Debtors
92.81
86.64
64.77
73.11
56.89
81.17
56.03
51.18
39.01
34.49
Cash & Bank
4.75
3.96
6.18
6.88
4.71
3.73
4.71
3.79
9.66
0.86
Other Current Assets
36.55
5.54
3.97
1.83
33.58
39.78
45.93
30.91
22.73
22.09
Short Term Loans & Adv.
34.26
37.98
47.57
37.33
32.65
38.23
45.02
29.53
21.46
21.46
Net Current Assets
82.55
72.85
57.96
43.23
31.93
11.78
42.25
29.86
10.11
8.90
Total Assets
370.21
349.36
311.70
293.34
263.79
275.04
299.03
263.30
250.45
237.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
31.00
25.41
25.77
15.87
28.63
46.30
2.79
14.88
35.01
17.79
PBT
28.84
31.66
22.89
24.76
10.72
-39.12
17.18
11.12
5.34
4.26
Adjustment
21.84
13.22
13.52
25.15
19.63
76.87
25.97
22.52
18.74
21.51
Changes in Working Capital
-11.98
-15.59
-7.56
-33.13
-1.71
8.58
-40.32
-18.68
10.88
-7.89
Cash after chg. in Working capital
38.70
29.30
28.84
16.78
28.64
46.32
2.82
14.95
34.96
17.88
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-7.15
-3.88
-3.07
-0.91
-0.01
-0.02
-0.04
-0.07
0.04
-0.09
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-0.55
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-12.52
-24.86
-10.96
-17.96
-9.07
-9.62
-9.33
-9.31
-9.81
1.01
Net Fixed Assets
-4.86
-5.66
-5.43
35.65
-4.54
195.52
-8.75
-7.37
-10.87
-4.91
Net Investments
-0.62
-0.60
-0.32
-0.53
-110.00
-39.20
0.00
0.00
0.00
3.52
Others
-7.04
-18.60
-5.21
-53.08
105.47
-165.94
-0.58
-1.94
1.06
2.40
Cash from Financing Activity
-18.06
-0.58
-15.02
1.97
-19.34
-36.90
6.69
-12.14
-18.84
-18.70
Net Cash Inflow / Outflow
0.42
-0.03
-0.21
-0.12
0.22
-0.22
0.14
-6.56
6.35
0.10
Opening Cash & Equivalents
0.41
0.44
0.66
0.78
0.56
0.79
0.65
7.21
0.86
0.76
Closing Cash & Equivalent
0.83
0.41
0.44
0.66
0.78
0.56
0.79
0.65
7.21
0.86

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
43.86
38.95
33.46
28.83
23.15
18.43
27.14
22.70
19.83
18.41
ROA
5.84%
7.27%
6.77%
7.15%
3.98%
-13.63%
6.11%
4.33%
2.19%
1.92%
ROE
11.74%
15.34%
15.21%
17.71%
12.19%
-43.06%
17.65%
13.39%
7.15%
6.60%
ROCE
13.69%
16.30%
13.88%
19.24%
13.09%
-12.48%
14.27%
11.81%
7.92%
6.88%
Fixed Asset Turnover
2.53
2.76
2.69
1.49
0.98
1.11
1.07
0.91
0.75
0.75
Receivable days
91.10
77.21
79.96
74.44
82.54
74.79
62.68
63.96
65.44
58.23
Inventory Days
82.21
73.66
76.30
68.37
62.26
53.60
52.48
50.98
59.89
53.30
Payable days
60.78
68.76
72.54
73.61
89.54
68.97
60.02
75.95
75.92
76.75
Cash Conversion Cycle
112.53
82.11
83.72
69.21
55.25
59.43
55.14
38.99
49.41
34.78
Total Debt/Equity
0.47
0.58
0.61
0.76
0.65
0.92
1.12
1.06
1.20
1.36
Interest Cover
4.17
4.52
3.66
2.81
1.85
-2.02
2.19
1.94
1.55
1.50

News Update:


  • Kopran’s arm receives approval from USFDA for supply of API Atenolol
    18th Jun 2020, 14:39 PM

    The company had filed the DMF of Atenolol, which has now been approved by the USFDA

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.